Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.

PHASE4RecruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

September 1, 2025

Study Completion Date

January 1, 2026

Conditions
Atrial Fibrillation
Interventions
DRUG

Antazoline

Participants assigned to the antazoline group will be administered antazoline in boluses in boluses of 100 mg diluted to 20 cm3 every 10 minutes up to a total dose of 300 mg diluted to 60 cm3 or conversion of AF to SR. Drug administration will also be stopped in case of an adverse event or conversion of AF to a different supraventricular arrhythmia. BP will be measured before every injection.

DRUG

Propafenone

Patients assigned to the propafenone group were administered three 20-cm3 boluses every 10 minutes up to 60 cm3 or conversion of AF to SR. Each of the first two boluses included 70 mg propafenone (total dose 140 mg), and the third bolus contained only 20-cm3 0.9% NaCl. Drug administration will be stopped in case of an adverse event or conversion of AF to a different supraventricular arrhythmia. BP will be measured before every injection.

Trial Locations (1)

00-685

RECRUITING

Postgraduate Medical School, Warsaw

All Listed Sponsors
lead

Centre of Postgraduate Medical Education

OTHER